Nathan Caffo - 29 Jul 2021 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role
Chief Business Officer
Signature
/s/ John Canepa, Attorney-in-Fact
Issuer symbol
CADL
Transactions as of
29 Jul 2021
Net transactions value
+$48,000
Form type
4
Filing time
02 Aug 2021, 20:02:54 UTC
Previous filing
26 Jul 2021
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Nathan Caffo filed Form 4 for Candel Therapeutics, Inc. (CADL) on 02 Aug 2021."

Quick Takeaways

  • This page summarizes Nathan Caffo's Form 4 filing for Candel Therapeutics, Inc. (CADL).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 02 Aug 2021, 20:02.

What Changed

  • Previous filing in this sequence was filed on 26 Jul 2021.
  • Current net transaction value: +$48,000.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CADL Common Stock Purchase $48,000 +6,000 $8.00* 6,000 29 Jul 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney

Sponsored